Ortho-Clinical Diagnostics has announced the FDA clearance and availability in the United States, Europe, and other international markets of an immunoassay that detects a key cardiac biomarker.
Read MoreA study of more than 33,000 women published in the June issue of the Journal of the National Cancer Institute found that testing for high-risk types of the human papillomavirus (HPV) is a significantly more sensitive tool for cervical cancer screening than either conventional or liquid-based cytology (Pap testing).
Read MoreThe Weisenthal Cancer Group has announced that clinical data presented at the annual meeting of the American Society of Clinical Oncology (ASCO) show that its new laboratory test accurately identified patients who would benefit from treatment with the molecularly-targeted anti-cancer therapies gefitinib (Iressaâ, AstraZeneca) and erlotinib (Tarcevaâ, Genentech).
Read MoreA look at some of the exhibitors participating in the AACC 2006 Clinical Lab Exposition, July 25–27, in Chicago. | Sponsored section Advanced Instruments Inc (Booth #1548) Advanced Instrumen
Read MoreIMPAC Names Hamilton and Fritz Laboratory Professionals of the Year IMPAC Medical Systems Inc has announced the recipients of the 2006 IMPAC Laboratory Professional of the Year award. Gr
Read More